Dubai resident Tommy Fleetwood will host three International Pathway Series events annually in the UAE, thanks to an exciting ...

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that we have completed enrollment ...

These pathways are potent oncogenic regulators of tumor cell growth, invasion, transformation, and survival. The EGFR is also implicated in angiogenesis, promotes invasiveness through matrix ...

Indonesia’s Randy Bintang shot an impressive five-under 65 to surge to the top of the leaderboard after round one of the Asia ...

AstraZeneca's EGFR inhibitor Tagrisso has been approved by the FDA for a new lung cancer indication that could make it a ...

Researchers from the University of Alabama at Birmingham have identified a promising new combination therapy for metastatic ...

Unlike other anti-IL-33 antibodies, tozorakimab has a dual mechanism of action that not only inhibits interleukin-33 signaling via the RAGE/EGFR pathway but also affects a separate ST2 receptor ...

Pacylex was recognized as BioAlberta's 2024 Company of the Year. The award acknowledges a company that has shown significant achievement within the marketplace and Alberta's business community through ...

Receptors such as EGFR, HER2, MET and ALK interface with common downstream signaling pathways and 'addiction switching' can occur, either by the inhibition of one receptor triggering a switch to ...

The FDA on Thursday approved xanomeline and trospium chloride (Cobenfy) for schizophrenia in adults, the first new class of ...

Munich, Germany, October 1, 2024 – (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the ...